| Michael Hageman » |
Translation of Injectable-to-Oral Peptide Pharmacotherapy: Application of E-Cadherin Binding Peptides as Oral Membrane Permeation Enhancers |
J.R. & Inez Jay Fund |
$20,000 |
07/01/2020 |
| Meredith Hartley » |
Thyroid hormone signaling during remyelination |
American Thyroid Association |
$50,000 |
07/01/2020 |
| Timothy Jackson » |
Graduate Training at the Biology-Chemistry Interface |
National Institutes of Health |
$1,928,225 |
07/01/2020 |
| Jennifer Robinson » |
Deciphering Sex Differences in Adolescent Knee Meniscal Injury and Regeneration |
University of Kansas Medical Center Research Institute |
$50,000 |
07/01/2020 |
| Frank Schoenen » |
Design synthesis analytical characterization eAMDE formulation sub-chronic MTD and in vivo PK of ML329 Prodrugs |
J.R. & Inez Jay Fund |
$20,000 |
07/01/2020 |
| Jingxin Wang » |
Mechanistic study of RNA splicing modulation by small molecules |
J.R. & Inez Jay Fund |
$20,000 |
07/01/2020 |
| Jingxin Wang » |
Small Molecule*Oligonucleotide Conjugate for the Tratment of Spinal Muscular Atrophy (SMA) with Improved Specificity |
Bionexus KC |
$50,000 |
07/01/2020 |
| Susan Lunte » |
Development of an integrated system for cell analysis and profiling by capillary electrophoresis-mass spectrometry |
NASA Space Technology Mission Directorate STMD |
$191,125 |
08/01/2020 |
| Jennifer Robinson » |
Promoting Temporomandibular Joint Fibrochondrogenesis through the use of an Estrogen Receptor Alpha Selective Agonist to Treat Osteoarthritis |
Howard Hughes Medical Institute |
$50,000 |
09/01/2020 |
| Rick Dobrowsky » |
A Novel Pharmacologic Approach to Treat CMT1X |
National Institutes of Health |
$387,165 |
09/15/2020 |
| Anthony Fehr » |
Determining mechanisms of innate immune modulation by ADP-ribosylation |
National Institutes of Health |
$1,680,080 |
09/15/2020 |
| David Davido » |
Role of CDKs in HSV-1 ICP0 functions |
University of Kansas Medical Center Research Institute |
$25,000 |
10/01/2020 |
| Brandon DeKosky » |
Bridge Proposal:Droplet-based single B and T cell receptor screening for multi-parameter adaptive immune monitoring |
University of Kansas Medical Center Research Institute |
$40,000 |
10/01/2020 |
| Teruna Siahaan » |
Non-Invasive Brain Delivery Clearance and Efficacy of Therapeutic Antibodies in Mice |
PHRMA Foundation |
$25,000 |
01/01/2021 |
| Yoshiaki Azuma » |
Targeting mitotic function of the PICH (Polo-like kinase interacting checkpoint helicase) for novel therapeutics of TNBC |
University of Kansas Medical Center Research Institute |
$35,000 |
01/01/2021 |
| Liang Xu » |
Drug the Undruggable Musashi Oncoprotein by Fragment-based Drug Discovery |
University of Kansas Medical Center Research Institute |
$35,000 |
01/01/2021 |
